These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12940439)

  • 1. Dual role of serum soluble E-cadherin as a biological marker of metastatic development in gastric cancer.
    Juhasz M; Ebert MP; Schulz HU; Röcken C; Molnar B; Tulassay Z; Malfertheiner P
    Scand J Gastroenterol; 2003 Aug; 38(8):850-5. PubMed ID: 12940439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma.
    Chan AO; Lam SK; Chu KM; Lam CM; Kwok E; Leung SY; Yuen ST; Law SY; Hui WM; Lai KC; Wong CY; Hu HC; Lai CL; Wong J
    Gut; 2001 Jun; 48(6):808-11. PubMed ID: 11358900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble E-cadherin fragments increased in circulation of cancer patients.
    Katayama M; Hirai S; Kamihagi K; Nakagawa K; Yasumoto M; Kato I
    Br J Cancer; 1994 Mar; 69(3):580-5. PubMed ID: 8123491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer.
    Chan AO; Chu KM; Lam SK; Wong BC; Kwok KF; Law S; Ko S; Hui WM; Yueng YH; Wong J
    J Clin Oncol; 2003 Jun; 21(12):2288-93. PubMed ID: 12805328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin.
    Chan AO; Chu KM; Lam SK; Cheung KL; Law S; Kwok KF; Wong WM; Yuen MF; Wong BC
    Cancer; 2005 Aug; 104(4):740-6. PubMed ID: 15991243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of soluble E-cadherin as a disease marker in gastric cancer patients.
    Gofuku J; Shiozaki H; Doki Y; Inoue M; Hirao M; Fukuchi N; Monden M
    Br J Cancer; 1998 Oct; 78(8):1095-101. PubMed ID: 9792157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
    BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
    Qiu M; Zhou Y; Zhang X; Wang Z; Wang F; Shao J; Lu J; Jin Y; Wei X; Zhang D; Wang F; Li Y; Yang D; Xu R
    BMC Cancer; 2014 Nov; 14():823. PubMed ID: 25380654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer.
    Velikova G; Banks RE; Gearing A; Hemingway I; Forbes MA; Preston SR; Jones M; Wyatt J; Miller K; Ward U; Al-Maskatti J; Singh SM; Ambrose NS; Primrose JN; Selby PJ
    Br J Cancer; 1997; 76(11):1398-404. PubMed ID: 9400933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence.
    Griffiths TR; Brotherick I; Bishop RI; White MD; McKenna DM; Horne CH; Shenton BK; Neal DE; Mellon JK
    Br J Cancer; 1996 Aug; 74(4):579-84. PubMed ID: 8761373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble E-cadherin as a diagnostic and prognostic marker in gastric carcinoma.
    Tsalikidis C; Papachristou F; Pitiakoudis M; Asimakopoulos B; Trypsianis G; Bolanaki E; Syrigos KN; Simopoulos C
    Folia Med (Plovdiv); 2013; 55(3-4):26-32. PubMed ID: 24712279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of a Li-cadherin in gastric cancer and intestinal metaplasia.
    Dong W; Yu Q; Xu Y
    Dig Dis Sci; 2007 Feb; 52(2):536-42. PubMed ID: 17226075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma.
    Lee SK; Moon J; Park SW; Song SY; Chung JB; Kang JK
    Oncol Rep; 2005 Feb; 13(2):193-9. PubMed ID: 15643498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LI-cadherin: a marker of gastric metaplasia and neoplasia.
    Grötzinger C; Kneifel J; Patschan D; Schnoy N; Anagnostopoulos I; Faiss S; Tauber R; Wiedenmann B; Gessner R
    Gut; 2001 Jul; 49(1):73-81. PubMed ID: 11413113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum soluble interleukin-2 receptor as a predictor of lymph node metastasis in early gastric cancer.
    Murakami S; Sakata H; Tsuji Y; Okubo K; Hamada S; Hirayama R
    Dig Surg; 2002; 19(1):9-13; discussion 14. PubMed ID: 11961349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients.
    Wilmanns C; Grossmann J; Steinhauer S; Manthey G; Weinhold B; Schmitt-Gräff A; von Specht BU
    Clin Exp Metastasis; 2004; 21(1):75-8. PubMed ID: 15065605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.
    Morohara K; Tajima Y; Nakao K; Nishino N; Aoki S; Kato M; Sakamoto M; Yamazaki K; Kaetsu T; Suzuki S; Tsunoda A; Tachikawa T; Kusano M
    J Cancer Res Clin Oncol; 2006 Jun; 132(6):363-75. PubMed ID: 16447040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas.
    Chen HC; Chu RY; Hsu PN; Hsu PI; Lu JY; Lai KH; Tseng HH; Chou NH; Huang MS; Tseng CJ; Hsiao M
    Cancer Lett; 2003 Nov; 201(1):97-106. PubMed ID: 14580691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.
    Zhou YN; Xu CP; Han B; Li M; Qiao L; Fang DC; Yang JM
    World J Gastroenterol; 2002 Dec; 8(6):987-93. PubMed ID: 12439911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers.
    Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ
    Digestion; 2001; 64(2):111-9. PubMed ID: 11684825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.